|
1
|
Jackman RW and Kandarian SC: Am J Physiol
Cell Physiol. 287:C834–843. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ibebunjo C, Chick JM, Kendall T, et al:
Genomic and proteomic profiling reveals reduced mitochondrial
function and disruption of the neuromuscular junction driving rat
sarcopenia. Mol Cell Biol. 33:194–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McKinnell IW and Rudnicki MA: Molecular
mechanisms of muscle atrophy. Cell. 119:907–910. 2004. View Article : Google Scholar
|
|
4
|
Romanick M, Thompson LV and Brown-Borg HM:
Murine models of atrophy, cachexia, and sarcopenia in skeletal
muscle. Biochim Biophys Acta. 1832:1410–1420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei B, Dui W, Liu D, et al: MST1, a key
player, in enhancing fast skeletal muscle atrophy. BMC Biology.
11:122013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nagpal P, Plant PJ, Correa J, et al: The
ubiquitin ligase Nedd4-1 participates in denervation-induced
skeletal muscle atrophy in mice. PloS One. 7:e464272012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nader GA: Molecular determinants of
skeletal muscle mass: getting the ‘AKT’ together. Int J Biochem
Cell Biol. 37:1985–1996. 2005.PubMed/NCBI
|
|
8
|
Ramamoorthy S, Donohue M and Buck M:
Decreased Jun-D and myogenin expression in muscle wasting of human
cachexia. Am J Physiol Endocrinol Metab. 297:E392–401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Menconi MJ, Arany ZP, Alamdari N, et al:
Sepsis and glucocorticoids downregulate the expression of the
nuclear cofactor PGC-1beta in skeletal muscle. Am J Physiol
Endocrinol Metab. 299:E533–543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tews DS, Behrhof W and Schindler S:
Expression patterns of initiator and effector caspases in
denervated human skeletal muscle. Muscle Nerve. 31:175–181. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bantscheff M, Boesche M, Eberhard D, et
al: Robust and sensitive iTRAQ quantification on an LTQ Orbitrap
mass spectrometer. Mol Cell Proteomics. 7:1702–1713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun H, Li M, Gong L, et al: iTRAQ-coupled
2D LC-MS/MS analysis on differentially expressed proteins in
denervated tibialis anterior muscle of Rattus norvegicus.
Mol Cell Biochem. 364:193–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sinclair J, Metodieva G, Dafou D, et al:
Profiling signatures of ovarian cancer tumour suppression using
2D-DIGE and 2D-LC-MS/MS with tandem mass tagging. J Proteomics.
74:451–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Szklarczyk D, Franceschini A, Kuhn M, et
al: The STRING database in 2011: functional interaction networks of
proteins, globally integrated and scored. Nucleic Acids Res.
39:D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun H, Zhu T, Ding F, et al: Proteomic
studies of rat tibialis anterior muscle during postnatal growth and
development. Mol Cell Biochem. 332:161–171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Menconi M, Gonnella P, Petkova V, et al:
Dexamethasone and corticosterone induce similar, but not identical,
muscle wasting responses in cultured L6 and C2C12 myotubes. J Cell
Biochem. 105:353–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sanada T, Kim M, Mimuro H, et al: The
Shigella flexneri effector OspI deamidates UBC13 to dampen
the inflammatory response. Nature. 483:623–626. 2012.
|
|
18
|
Paul PK, Bhatnagar S, Mishra V, et al: The
E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal
muscle atrophy through multiple mechanisms. Mol Cell Biol.
32:1248–1259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones A, Hwang DJ, Narayanan R, et al:
Effects of a novel selective androgen receptor modulator on
dexamethasone-induced and hypogonadism-induced muscle atrophy.
Endocrinology. 151:3706–3719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Pickrell AM, Rossi SG, et al:
Transient systemic mtDNA damage leads to muscle wasting by reducing
the satellite cells pool. Hum Mol Genet. 22:3976–3986. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calvani R, Joseph AM, Adhihetty PJ, et al:
Mitochondrial pathways in sarcopenia of aging and disuse muscle
atrophy. Biol Chem. 394:393–414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Picard M, Ritchie D, Thomas MM, et al:
Alterations in intrinsic mitochondrial function with aging are
fiber type-specific and do not explain differential atrophy between
muscles. Aging Cell. 10:1047–1055. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun H, Liu J, Ding F, et al: Investigation
of differentially expressed proteins in rat gastrocnemius muscle
during denervation-reinnervation. J Muscle Res Cell Motil.
27:241–250. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Keller A, Peltzer J, Carpentier G, et al:
Interactions of enolase isoforms with tubulin and microtubules
during myogenesis. Biochim Biophys Acta. 1770:919–926. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Merkulova T, Dehaupas M, Nevers MC, et al:
Differential modulation of alpha, beta and gamma enolase isoforms
in regenerating mouse skeletal muscle. Eur J Biochem.
267:3735–3743. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Merkulova T, Lucas M, Jabet C, et al:
Biochemical characterization of the mouse muscle-specific enolase:
developmental changes in electrophoretic variants and selective
binding to other proteins. Biochem J. 323(Pt 3): 791–800. 1997.
|
|
27
|
Comi GP, Fortunato F, Lucchiari S, et al:
Beta-enolase deficiency, a new metabolic myopathy of distal
glycolysis. Ann Neurol. 50:202–207. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seweryn E, Pietkiewicz J, Szamborska A, et
al: Enolase on the surface of prokaryotic and eukaryotic cells is a
receptor for human plasminogen. Postepy Hig Med Dosw (Online).
61:672–682. 2007.(In Polish).
|
|
29
|
Díaz-Ramos A, Roig-Borrellas A,
García-Melero A, et al: Requirement of plasminogen binding to its
cell-surface receptor alpha-enolase for efficient regeneration of
normal and dystrophic skeletal muscle. PloS One.
7:e504772012.PubMed/NCBI
|
|
30
|
Díaz-Ramos A, Roig-Borrellas A,
García-Melero A, et al: alpha-Enolase, a multifunctional protein:
its role on pathophysiological situations. J Biomed Biotechnology.
2012:1567952012.PubMed/NCBI
|
|
31
|
Aaronson RM, Graven KK, Tucci M, et al:
Non-neuronal enolase is an endothelial hypoxic stress protein. J
Biol Chem. 270:27752–27757. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fontán PA, Pancholi V, Nociari MM, et al:
Antibodies to streptococcal surface enolase react with human
α-enolase: implications in poststreptococcal sequelae. J Infect
Dis. 182:1712–1721. 2000.PubMed/NCBI
|
|
33
|
Paul PK, Gupta SK, Bhatnagar S, et al:
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in
mice. J Cell Biol. 191:1395–1411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao W, Pan J, Zhao Z, et al: Testosterone
protects against dexamethasone-induced muscle atrophy, protein
degradation and MAFbx upregulation. J Steroid Biochem Mol Biol.
110:125–129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Castillero E, Alamdari N, Lecker SH, et
al: Suppression of atrogin-1 and MuRF1 prevents
dexamethasone-induced atrophy of cultured myotubes. Metabolism.
62:1495–1502. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Castillero E, Alamdari N, Aversa Z, et al:
PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1
activation and muscle wasting. PloS One. 8:e597262013.
|
|
37
|
Suetta C, Frandsen U, Jensen L, et al:
Aging affects the transcriptional regulation of human skeletal
muscle disuse atrophy. PloS One. 7:e512382012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Caron AZ, Haroun S, Leblanc E, et al: The
proteasome inhibitor MG132 reduces immobilization-induced skeletal
muscle atrophy in mice. BMC Musculoskelet Disord. 12:1852011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Caron AZ, Drouin G, Desrosiers J, et al: A
novel hindlimb immobilization procedure for studying skeletal
muscle atrophy and recovery in mouse. J Appl Physiol.
106:2049–2059. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Paul PK and Kumar A: TRAF6 coordinates the
activation of autophagy and ubiquitin-proteasome systems in
atrophying skeletal muscle. Autophagy. 7:555–556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao PR, Kim HJ and Lecker SH:
Ubiquitin-protein ligases in muscle wasting. Int J Biochem Cell
Biol. 37:2088–2097. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang L, Tang H, Kou Y, et al:
MG132-mediated inhibition of the ubiquitin-proteasome pathway
ameliorates cancer cachexia. J Cancer Res Clin Oncol.
139:1105–1115. 2013. View Article : Google Scholar : PubMed/NCBI
|
